Media Summary: Merrick Ross, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses key challenges in Kohei Shitara, MD, National Cancer Center Hospital East, Chiba, Japan, discusses a range of Mass General Cancer Center's Dr. Keith Flaherty discusses
Optimizing Immunotherapy Predictive Biomarkers Resistance - Detailed Analysis & Overview
Merrick Ross, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses key challenges in Kohei Shitara, MD, National Cancer Center Hospital East, Chiba, Japan, discusses a range of Mass General Cancer Center's Dr. Keith Flaherty discusses Mark Yarchoan, MD, Johns Hopkins University, Baltimore, MD, provides an overview of emerging Paolo Ascierto, MD of the National Tumor Institute Fondazione G. Pascale, Naples, Italy discusses Randy Sweis, MD, of the University of Chicago Medical Center, Chicago, IL, speaks at the 2019 Genitourinary Cancers ...
Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment. Dr Eliezer Van Allen, Assistant Professor at Harvard Medical School and Medical Oncologist at the Dana Farber Cancer Institute, ... As explained here by James Spicer, PhD, FRCP, of Guy's and St Thomas' NHS Foundation Trust, London, UK, the field of lung ... Hans Christian Kolberg, MD, Marienhospital Bottrop, Bottrop, Germany, reviews prevalent Howard Kaufman, MD, FACS, Ankyra Therapeutics and Massachusetts General Hospital, Boston, MA, talks on recent advances in ... Panelists Mark A. Socinski, MD; Manish A. Shah, MD; Yelena Y. Janjigian, MD; Roy S. Herbst, MD, PhD; and Johanna Bendell, ...
